SNPS is moving forward with expanding its Thai herbal business capabilities by building a new plant in Bang Phli, which will be completed by the end of 2026, to support the production of medicines and medical devices derived from active ingredients of herbal plants. The company targets revenue growth of 15-30% this year compared to the previous year and believes its performance will still meet targets, as the first half of the year saw total revenue of 259.19 million baht. It also maintains a gross profit margin of around 40% and a net profit margin of around 17%. Meanwhile, the new plant has a construction investment budget of approximately 175.90 million baht and a land lease contract budget of around 50.48 million baht over a 30-year period. According to an analysis by Yuanta Securities (Thailand), normal profit in the second half of 2026 is expected to recover from the first half, reaching 26 million baht per quarter, due to the illness season and revenue from new products in the artificial saliva group. However, profit will still decline compared to the same period last year due to weak gross profit margins. The normal profit estimates for 2026-2027 are 96 million baht and 113 million baht, respectively.
Specialty Natural Products PCLCompany expanding with new plant and targeting revenue growth, with analyst estimates provided.
